Tiberiu Stan
tibisan.bsky.social
Tiberiu Stan
@tibisan.bsky.social
Excited to attend the Oligonucleotide Therapeutics Society (OTS) Annual Meeting in Budapest!

👉Poster P222 on Tuesday, Oct 21:
“Sustained Muscle Function Improvement After a Single In Vivo Dose of Antibody Oligonucleotide Conjugate (AOC) in the mdx Mouse Model for Duchenne Muscular Dystrophy.”
October 21, 2025 at 2:30 AM
🔬 Research Technician Human Genetics

Are you seeking a meaningful role where you can apply your expertise to advance the treatment of Duchenne muscular dystrophy? We have an opening for research technician position in our group:
www.lumc.nl/en/about-lum...
Research Technician Human Genetics | LUMC
Are you seeking a meaningful role where you can apply your expertise to advance the treatment of Duchenne muscular dystrophy? In our Validation Lab, you’ll work alongside a dedicated and skilled team ...
www.lumc.nl
April 14, 2025 at 10:24 AM
A second paper from my former post doc lab in Lund has been accepted recently to EJN and I am sharing (again) the first authorship😊
Neurophysiological treatment effects of mesdopetam, pimavanserin and amantadine in a rodent model of levodopa-induced dyskinesia
www.authorea.com/users/837293...
Neurophysiological treatment effects of mesdopetam, pimavanserin and amantadine in a rodent model of levodopa-induced dyskinesia
Levodopa provides effective symptomatic treatment for Parkinson’s disease. However, non-motor symptoms are often insufficiently relieved, and its long-term use is complicated by motor fluctuations and...
www.authorea.com
February 21, 2025 at 10:16 AM